Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    19269895 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas
Condition: Grade II/III Glioma
Interventions: Drug: Temozolomide;   Radiation: Radiotherapy
2 Not yet recruiting Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors
Condition: Brain Tumor
Intervention: Drug: Demeclocycline
3 Recruiting Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
Condition: Glioblastoma
Intervention:
4 Recruiting Spatial Analysis and Validation of Glioblastoma on 7 T MRI
Condition: Glioblastoma
Interventions: Device: 7 T MRI;   Procedure: Biopsy
5 Recruiting Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
Condition: Recurrent Glioblastoma Multiforme
Interventions: Radiation: Stereotactic hypofractionated RT 5x5Gy;   Radiation: Stereotactic hypofractionated RT 5x7Gy
6 Withdrawn Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
Conditions: Astrocytoma, Grade IV;   Giant Cell Glioblastoma;   Glioblastoma Multiforme
Interventions: Radiation: External-beam radiation therapy;   Drug: Temozolomide
7 Completed Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Radiation: radiation therapy

Indicates status has not been verified in more than two years